by rss feed | Jul 8, 2025 | ALS, BrainStorm Cell Therapeutics, News Feeds, NurOwn
ALS is a devastating, incurable disease that urgently needs innovative treatments and cell therapies have potential, but so far data on the most prominent candidate cellular drug, Nurown from BrainStorm Cell Therapeutics, have not convinced the FDA to approve it. The...
by rss feed | Sep 26, 2023 | ALS, BrainStorm Cell Therapeutics, FDA, News Feeds, NurOwn
BrainStorm Cell Therapeutics is developing Nurown, an investigational therapy intended for treating ALS. I recently posted about BrainStorm and its prospects for providing real hope on stem cells for ALS. I see it as a long shot. The ALS community needs real hope, but...
by rss feed | May 7, 2023 | ALS, Clive Svendsen, News Feeds, Stem cells for ALS, weekly reads
I’ve been writing The Niche now for more than 13 years and the idea of stem cells for ALS has been around that whole time. Unfortunately, it has been slow going on this front, but there are still reasons for hope. Probably now much more than ever before....
by rss feed | Feb 22, 2023 | ALS, BrainStorm Cell Therapeutics, Informational, News Feeds, NurOwn
What is the cell therapy for ALS called NurOwn? How strong is its potential as a treatment for ALS? I’ve been following the biotech BrainStorm Cell Therapeutics for many years. Patients keep asking me about NurOwn ALS prospects. They’re looking for hope....
